[HTML][HTML] Pancreatic endocrine neoplasms: epidemiology and prognosis of pancreatic endocrine tumors
TR Halfdanarson, J Rubin, MB Farnell… - Endocrine-related …, 2008 - ncbi.nlm.nih.gov
Pancreatic endocrine neoplasms (PETs) are uncommon tumors with an annual incidence
less than 1 per 100,000 persons per year in the general population. PETs that produce …
less than 1 per 100,000 persons per year in the general population. PETs that produce …
[HTML][HTML] Retinal very long-chain PUFAs: new insights from studies on ELOVL4 protein
MP Agbaga, MNA Mandal, RE Anderson - Journal of lipid research, 2010 - ASBMB
Compared with other mammalian tissues, retina is highly enriched in PUFA. Long-chain
PUFA (LC-PUFA; C18-C24) are essential FAs that are enriched in the retina and are …
PUFA (LC-PUFA; C18-C24) are essential FAs that are enriched in the retina and are …
MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis
M Bloomston, WL Frankel, F Petrocca, S Volinia… - Jama, 2007 - jamanetwork.com
ContextWhile global microRNA (miRNA) expression patterns of many embryologic,
physiologic, and oncogenic processes have been described, description of the role of …
physiologic, and oncogenic processes have been described, description of the role of …
Pancreatic endocrine tumors: expression profiling evidences a role for AKT-mTOR pathway
E Missiaglia, I Dalai, S Barbi, S Beghelli… - Journal of clinical …, 2010 - ascopubs.org
Purpose We investigated the global gene expression in a large panel of pancreatic
endocrine tumors (PETs) aimed at identifying new potential targets for therapy and …
endocrine tumors (PETs) aimed at identifying new potential targets for therapy and …
[HTML][HTML] New insights into the structure and mechanism of iodothyronine deiodinases
U Schweizer, C Steegborn - Journal of molecular …, 2015 - jme.bioscientifica.com
Pancreatic neuroendocrine tumours (PETs) are the second most frequent pancreatic
neoplasms. Their poor chemosensitivity, high rate of metastatic disease and relatively long …
neoplasms. Their poor chemosensitivity, high rate of metastatic disease and relatively long …
[HTML][HTML] Gene expression profiles of progressive pancreatic endocrine tumours and their liver metastases reveal potential novel markers and therapeutic targets
G Capurso, S Lattimore… - Endocrine-related …, 2006 - erc.bioscientifica.com
The intrinsic nature of tumour behaviour (stable vs progressive) and the presence of liver
metastases are key factors in determining the outcome of patients with a pancreatic …
metastases are key factors in determining the outcome of patients with a pancreatic …
Molecular genetics of neuroendocrine tumors
EM Duerr, DC Chung - Best Practice & Research Clinical Endocrinology & …, 2007 - Elsevier
Neuroendocrine tumors can develop either sporadically or in association with familial
syndromes such as multiple endocrine neoplasia type 1 (MEN1), multiple endocrine …
syndromes such as multiple endocrine neoplasia type 1 (MEN1), multiple endocrine …
[PDF][PDF] Defining molecular classifications and targets in gastroenteropancreatic neuroendocrine tumors through DNA microarray analysis
EM Duerr, Y Mizukami, A Ng, RJ Xavier… - Endocrine-related …, 2008 - Citeseer
Current classifications of human gastroenteropancreatic neuroendocrine tumors (NETs) are
inconsistent and based upon histopathologic but not molecular features. We sought to …
inconsistent and based upon histopathologic but not molecular features. We sought to …
[HTML][HTML] Molecular pathology of pancreatic neuroendocrine tumors
M Chen, M Van Ness, Y Guo… - Journal of gastrointestinal …, 2012 - ncbi.nlm.nih.gov
Pancreatic endocrine tumors (PETs) are rare neoplasms which account for 1% to 2% of all
pancreatic malignancies. The diagnostic, grading and prognostic criteria for PETs have …
pancreatic malignancies. The diagnostic, grading and prognostic criteria for PETs have …
GeneChip, geNorm, and gastrointestinal tumors: novel reference genes for real-time PCR
Accurate quantitation of target genes depends on correct normalization. Use of genes with
variable tissue transcription (GAPDH) is problematic, particularly in clinical samples, which …
variable tissue transcription (GAPDH) is problematic, particularly in clinical samples, which …